Aimable Nahimana
6PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 02, 2025
CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma.Giulia Giorgetti, Elena Maroto-Martin, Debora Soncini
|Dec 11, 2024
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma.Debora Soncini, Pamela Becherini, Francesco Ladisa
|Feb 25, 2023
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies.Paulina Biniecka, Saki Matsumoto, Axel Belotti
|Feb 11, 2023
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia.Saki Matsumoto, Paulina Biniecka, Axel Bellotti
|Apr 09, 2022
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.Oussama ElMokh, Saki Matsumoto, Paulina Biniecka
|Sep 06, 2018
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.Maxime Pellegrin, Karima Bouzourène, Jean-François Aubert
Pageof 1
Frequent Collaborators
3 joint publications
Saki Matsumoto
3 joint publications
Paulina Biniecka
2 joint publications
Alessio Nencioni
2 joint publications
Michel A Duchosal
2 joint publications
Giulia Giorgetti
2 joint publications
Francesco Ladisa
2 joint publications
Michele Cea
1 joint publications
Maxime Pellegrin
1 joint publications
Jian Fei Bai
1 joint publications
Michele Cea
